Your session is about to expire
← Back to Search
local antibiotics and surgery for Gum Disease
Phase 3
Waitlist Available
Led By J Max Goodson, DDS, PhD
Research Sponsored by The Forsyth Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The purpose of this study is to test combined effects of scaling and root planing with periodontal surgery, systemically administered amoxicillin and metronidazole, and/or local tetracycline on pocket depth reduction and attachment level "gain" in patients with chronic periodontitis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
8Treatment groups
Experimental Treatment
Active Control
Group I: systemic antibiotics and surgeryExperimental Treatment1 Intervention
Group II: systemic antibioticsExperimental Treatment1 Intervention
Group III: local antibiotics and surgeryExperimental Treatment1 Intervention
Group IV: local antibiotic and systemic antibioticsExperimental Treatment1 Intervention
Group V: local and systemic antibiotics and surgeryExperimental Treatment1 Intervention
Group VI: Periodontal surgeryExperimental Treatment1 Intervention
Group VII: Local delivery of tetracyclineExperimental Treatment1 Intervention
Group VIII: Scaling and root planingActive Control1 Intervention
scaling and root planing as a solo therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tetracycline
FDA approved
Amoxicillin
FDA approved
Amoxicillin
FDA approved
Find a Location
Who is running the clinical trial?
The Forsyth InstituteLead Sponsor
14 Previous Clinical Trials
1,550 Total Patients Enrolled
Göteborg UniversityOTHER
425 Previous Clinical Trials
1,021,785 Total Patients Enrolled
Boston UniversityOTHER
467 Previous Clinical Trials
9,954,081 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger